Interestingly, tumor angiogenesis and tumor growth were both inhibited by interfering with the interaction between KIF13B and VEGFR2 by the peptide kinesin-derived angiogenesis inhibitor (KAI) (Yamada et al, 2017). The gene discussed is KIF13B; the disease is neoplasm.